AHCO INVESTOR ALERT: Investigation of AdaptHealth Corp. Announced by Holzer & Holzer, LLC

Holzer & Holzer, LLC is investigating whether AdaptHealth Corp. (“AdaptHealth” or the “Company”) (NASDAQ: AHCO) complied with federal securities laws. On August 4, 2026, AdaptHealth revised its financial guidance and announced second quarter 2026 results, revealing that “[c]ash flow from operations was $239.0 million year-to-date 2026, a decrease from $257.5 million during the comparable period in 2025, and free cash flow was negative $48.4 million year-to-date 2026, compared to $73.3 million during the comparable period in 2025.” AdaptHealth attributed the results in part to its “West Coast capitated partnership reach[ing] full scale in the quarter, and the complexity of the transition” impacting margins. On this news, the price of the Company’s stock dropped.